Lipid Management in Patients With Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization
Open Access
- 10 January 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 165 (1), 49-54
- https://doi.org/10.1001/archinte.165.1.49
Abstract
Despite longstanding efficacy data for managing dyslipidemias, a significant gap remains between widely accepted,evidence-based treatment guidelines and routine clinical practice.1-8 Fewer than 32% of patients hospitalized with acute myocardial infarction receive lipid-lowering therapy at the time of discharge.8 Overall, only 37% of patients with documented coronary artery disease (CAD) attain target low-density lipoprotein cholesterol (LDL-C) levels less than 100 mg/dL (7 Even when prescribed appropriate therapy, patients with CAD discontinue lipid-lowering medications at rates as high as 60% during the first year.9,10Keywords
This publication has 2 references indexed in Scilit:
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderlyThe American Journal of Cardiology, 1995